Literature DB >> 25350316

One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China.

X-J Wu1, X-M Pu, X-J Kang, Y Halifu, C-X An, D-Z Zhang, B Yakeya, J Mijit.   

Abstract

BACKGROUND: Kaposi's sarcoma (KS) is an unusual illness that may be associated with human herpes virus 8 (HHV-8) infections, and appears mainly in Jews, Italians and Greeks. There is a lack of patient data in Xinjiang regarding the clinical characteristics of KS.
OBJECTIVES: To review the clinical characteristics of a series of patients with KS in Xinjiang, Northwest China, over 16-year period.
METHODS: A retrospective analysis of patients referred to a Xinjiang hospital in Northwest China with classic KS (CKS) and AIDS-associated KS (AIDS-KS) between January 1997 and April 2013 was performed. Reviewed information included demographics, clinical features, histopathological traits, treatment and presence of HHV-8 infection.
RESULTS: During the study period, 105 patients with a diagnosis of KS, including 77 CKS and 28 AIDS-KS, were referred to our hospital. Mean age at diagnosis was 55.8 ± 16.8 years (range: 25-85 years). There were 70 (90.9%) males and 7 (9.1%) females (male-to-female ratio: 10 : 1) having CKS and 21 (75.0%) males and 7 (25.0%) females (male-to-female ratio: 3 : 1) with AIDS-KS. Most of the patients were Uyghur, including 67 CKS and 24 AIDS-KS. The rate of multifocal lesions at diagnosis was 98.1% (103/105). The most common area of lesions was between 1% and 5% of CKS and AIDS-KS. The main types of lesions were nodules, patches and plaques. The lower extremity and foot were the most common locations for CKS and AIDS-KS. In addition to skin damage, the penis, mouth, lymph nodes and interstitial lung tissues were involved in some cases. No second primary malignancy was diagnosed. Systemic chemotherapy and radiotherapy were effective treatments for CKS. The HHV-8 positivity rate was 98.98% in 98 KS cases.
CONCLUSIONS: In Xinjiang, most CKS and AIDS-KS patients were older Uyghur men. AIDS-KS was found predominantly among 30-year-old Uyghur patients, compared with 60 years for those having CKS. The latter exhibited certain characteristics such as disseminated skin disease; in some patients, the condition was accompanied by lymphedema, visceral or lymph node involvement, but no secondary malignancies. In addition, the HHV-8 positivity rate associated with KS was very high.
© 2013 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2013        PMID: 25350316     DOI: 10.1111/jdv.12349

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  9 in total

1.  The expression profiles of microRNAs in Kaposi's sarcoma.

Authors:  Xiu-Juan Wu; Xiong-Ming Pu; Zong-Feng Zhao; Ya-Nan Zhao; Xiao-Jing Kang; Wei-Dong Wu; Yun-Min Zou; Cao-Ying Wu; Yuan-Yuan Qu; De-Zhi Zhang; Yan-Yan Feng; Jian-Yong Liu
Journal:  Tumour Biol       Date:  2014-10-01

Review 2.  Regulation of sex hormone receptors in sexual dimorphism of human cancers.

Authors:  Daoshan Zheng; Cecilia Williams; Jeremy A Vold; Justin H Nguyen; Denise M Harnois; Sanjay P Bagaria; Sarah A McLaughlin; Zhaoyu Li
Journal:  Cancer Lett       Date:  2018-09-14       Impact factor: 8.679

3.  Incidence of Kaposi Sarcoma in Sweden is Decreasing.

Authors:  Giedre Bieliauskiene; Oscar Zaar; Isabel Kolmodin; Martin Gillstedt; John Paoli
Journal:  Acta Derm Venereol       Date:  2020-10-28       Impact factor: 3.875

4.  Differential expression of microRNAs in the normal skin of the Han and Uyghur populations in Xinjiang Province.

Authors:  Xiujuan Wu; Zongfeng Zhao; Yuan Ding; Fang Xiang; Xiaojing Kang; Xiongming Pu
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

5.  Extensive cutaneous iatrogenic Kaposi's sarcoma after bullous pemphigoid treatment with oral methylprednisolone: a rare Chinese case report.

Authors:  Sheng-An Chen; Lan-Ting Wang; Zi-Hua Chen; Fan-Ping Yang; Qin-Yuan Zhu; Hu-Yan Chen; Xiao-Qun Luo
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

6.  Prevalence and Risk Factors of Kaposi's Sarcoma-Associated Herpesvirus Infection among Han and Uygur Populations in Xinjiang, China.

Authors:  Zhi Wen; Wenli Li; Yuan Fang; Chang Zhou; Kang Lin; Huanwu Wu; Yiting Zhang; Yulin Zhu; Xingchen Xu; Yan Zeng; Baojing Lu; Linding Wang
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-12-31       Impact factor: 2.471

7.  Evaluation of the relationship between c-Kit expression and mean platelet volume in classic Kaposi's sarcoma.

Authors:  Ibrahim Sehitoglu; Recep Bedir; Erkan Cure; Medine Cumhur Cure; Suleyman Yuce; Nursel Dilek
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

8.  MicroRNA-126-3p suppresses cell proliferation by targeting PIK3R2 in Kaposi's sarcoma cells.

Authors:  Xiu-Juan Wu; Zong-Feng Zhao; Xiao-Jing Kang; Hong-Juan Wang; Juan Zhao; Xiong-Ming Pu
Journal:  Oncotarget       Date:  2016-06-14

9.  The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study.

Authors:  Can Baykal; Tugba Atci; Nesimi Buyukbabani; Armagan Kutlay
Journal:  Indian J Dermatol       Date:  2019 Sep-Oct       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.